Last updated on May 2008

A Study of Hemopure to Enhance Tissue Preservation During Cardiopulmonary Bypass Surgery


Brief description of study

The purpose of this study is to determine if Hemopure® will enhance tissue preservation during Cardiopulmonary Bypass surgery.

Detailed Study Description

The primary objective is to determine the safety and feasibility of administering Hemopure® (HBOC-201) to reduce myocardial necrosis, as measured by CK-MB enzyme elevation, and enhance tissue preservation during cardiopulmonary bypass.

Clinical Study Identifier: NCT00301535

Contact Investigators or Research Sites near you

Start Over

Antonis Pitsis, MD

Thessaloniki Heart Institute - St. Luke's Hospital
Thessaloniki, Greece
  Connect »

Martin Sussman, MD

Milpark Hospital
Johannesburg, South Africa
  Connect »

Stephen Westaby, MD

Oxford Heart Centre - John Radcliffe Hospital
Headington, United Kingdom
  Connect »